Imaging nigral pathology and clinical progression in Parkinson's disease.
about
The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effectsMicrostructural changes in the substantia nigra of asymptomatic agricultural workersThe evolving role of diffusion magnetic resonance imaging in movement disordersMRI reveals brain abnormalities in drug-naive Parkinson's disease.Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.Free-water imaging in Parkinson's disease and atypical parkinsonism.Why psychosis is frequently associated with Parkinson's disease?A Method for Automated Classification of Parkinson's Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI.Chemical Exchange Saturation Transfer MR Imaging is Superior to Diffusion-Tensor Imaging in the Diagnosis and Severity Evaluation of Parkinson's Disease: A Study on Substantia Nigra and Striatum.Parkinson's disease biomarkers program brain imaging repository.Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication.The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Diffusion Kurtosis Imaging of Substantia Nigra Is a Sensitive Method for Early Diagnosis and Disease Evaluation in Parkinson's Disease.Stage-dependent loss of cortical gyrification as Parkinson disease "unfolds"The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regionsCombining Diffusion Tensor Imaging and Susceptibility Weighted Imaging on the Substantia Nigra of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP)-induced Rhesus Monkey Model of Parkinson's Disease.Combined Diffusion Tensor Imaging and Arterial Spin Labeling as Markers of Early Parkinson's disease.Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.Dopamine overdose hypothesis: evidence and clinical implications.T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.Multi-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline.Quantitative susceptibility mapping of the midbrain in Parkinson's diseaseMicrostructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes.Diffusion tensor imaging in Parkinson's disease: Review and meta-analysisLateralized basal ganglia vulnerability to pesticide exposure in asymptomatic agricultural workers.Functional MRI of disease progression in Parkinson disease and atypical parkinsonian syndromesIn vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.Neuroimaging in Parkinson's disease: a future perspective.Magnetic resonance imaging for the diagnosis of Parkinson's disease.Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.T2* Relaxometry in Patients with Parkinson's Disease : Use of an Automated Atlas-based Approach.Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture.UNC-Utah NA-MIC framework for DTI fiber tract analysis.Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease.Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.Diffusion imaging of nigral alterations in early Parkinson's disease with dopaminergic deficits.Differential involvement of nigral subregions in idiopathic parkinson's disease.Progression marker of Parkinson's disease: a 4-year multi-site imaging study.
P2860
Q28396222-A9C01F3C-B877-4ED8-859D-AAE145FDD1E4Q28397004-B70316D7-724A-4F17-B73C-B082A6763BDFQ30667544-3EA02352-486D-42C4-85FF-C9D426F28137Q30688718-E76F87FB-DEAB-40F1-9E40-BC6EB6AF9C0FQ30873974-6F33EB29-BA25-4C13-920C-AA9BB1CC74F6Q31034031-685D22EF-DB15-48A3-A247-939BB39C1961Q34094668-841A2C63-F2DF-4191-B659-5FD97D2E4906Q36046525-0BC9B04D-CABF-4175-AD1F-86279DC1E63CQ36174326-3BA2A20A-2192-4F56-9A31-0FB03B29A4C1Q36276040-6220FB71-CB8E-4F2F-89E2-D69826AA8E90Q36301580-453352F0-A2BF-4E47-90D2-B124D9F3EAD4Q36332532-8BE38192-2C35-4319-9B3A-4F02702164A6Q36374541-83ECE09C-6548-4887-9801-D7CB5112D083Q36378779-12ED4E3D-B26D-404A-9BA4-FCB11ACC5210Q36763365-3EC6C5D7-4D1C-4261-9A75-DB7FFE6F47CAQ36818525-1EDF96D0-6A70-41E1-A653-9894A4085A1CQ37127188-21C3CF2A-E81A-41E0-A8EB-B95615BCDCB0Q37267022-F1FDE689-545D-4E61-AC31-1D70FE666BCBQ37313955-B94B01EF-3325-4067-BA8A-29BDFC33BAF2Q37384960-B20F0DE8-1CE0-4D68-A208-A69BFC04DB80Q37396921-854D9AD8-8054-4B99-B8E9-7D8BB2425AC5Q37558908-30F4ECB7-07EE-439F-8AF1-B710D4C27C76Q37650486-6990C007-6AE4-43CE-B7F3-C56D1778648FQ38592102-150AF39F-F574-47DF-BE8F-0D4DF7AFCDD1Q38647751-AFACA45F-87CA-44AE-94D2-EBB6F4F39970Q38668885-E9EBFBAE-A30D-4670-9183-A06A3A2BF8C9Q38841452-2D510539-BDE6-4667-9593-012E41CC9C68Q38940194-4A314AD5-40EE-4635-8B39-B2A0F0F5FCE3Q39015987-EAB9ADDA-E7D2-48D5-8B12-A4D903B75009Q39220904-B4979B21-2328-4A06-A2FB-CECD697CBFC4Q40016191-1044CC24-9FD4-42C9-8710-CAD64CF376E6Q40202363-72F13BD8-7E4E-476F-B0EB-E4E3CF737A47Q40384244-87DC83ED-E7C9-4DEB-B1DA-F69DAA619C21Q40789536-8D99C54D-5FB8-4879-85A2-05BD3F9E8470Q41860688-EA76E592-718E-44A4-AB55-3358D1DB420BQ42484375-F5EF2AEF-4F26-4BAF-85A2-342793611118Q43067221-3AC1EB1B-D2D8-4CCF-81AA-9083D91B626CQ46262004-22B85059-77FE-447A-9769-8C48F1F2DAEBQ47416232-847D91D4-93C3-462B-87F0-AEB2D7C31C27Q47683720-B181768E-28F8-4046-847B-7C01568E345E
P2860
Imaging nigral pathology and clinical progression in Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Imaging nigral pathology and clinical progression in Parkinson's disease.
@ast
Imaging nigral pathology and clinical progression in Parkinson's disease.
@en
type
label
Imaging nigral pathology and clinical progression in Parkinson's disease.
@ast
Imaging nigral pathology and clinical progression in Parkinson's disease.
@en
prefLabel
Imaging nigral pathology and clinical progression in Parkinson's disease.
@ast
Imaging nigral pathology and clinical progression in Parkinson's disease.
@en
P2093
P2860
P356
P1433
P1476
Imaging nigral pathology and clinical progression in Parkinson's disease.
@en
P2093
Guangwei Du
Jianli Wang
Mechelle M Lewis
Michele L Shaffer
Qing X Yang
P2860
P304
P356
10.1002/MDS.25182
P407
P577
2012-09-24T00:00:00Z